Endeavor
57 article(s) found
![](/contentassets/24f1fd7099bd4464af1ca5cf7172f0c6/2022_yir-1440.jpg)
Top 10 Moffitt Stories of 2022
![](/contentassets/d48930a69e494c2c879c3dade1762038/lambert-car-t-1400.jpg)
CAR T Puts Moffitt Patient in an Exclusive Club
![](/contentassets/603b4a66d70f4f06b9dd9bcbee15ac0f/ash-overview-1440.jpg)
Moffitt’s Blood Cancer Experts Share the Latest Research and Treatment Advances
![](/contentassets/afdbf8d2cde34490b47ff4acedb02734/sallman-car-t-1440.gif)
Donor CAR T May Increase Remission in Relapsed or Refractory AML Patients
![](/contentassets/703c054470884ef2a925018622d6864a/study-highlights-potential-race-disparities-1440.jpg)
Study Highlights Potential Disparities for CAR T Patients with Multiple Myeloma
![](/contentassets/bd9002b207554a6487ffc689e832f190/ice-t-1400.jpg)
Expanding Targets for Cell Therapy
![](/contentassets/96223cd0cccc401193afb9f723377113/bridiging-radiation-1400.jpg)
Can Bridging Radiation Therapy Increase Success of CAR T?
![](/contentassets/28b3e8f1f476436a98362873cea4fb34/akens-1440.jpg)
Moffitt Cancer Center’s Clinical Trials Focus on Expansion, Diversity and Innovation
![](/contentassets/e85eb19a013944ab9237861f512ad98b/t-cells-attack-1440.jpg)
Autologous vs. Allogeneic CAR T